{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:20:52Z","timestamp":1793924452936,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cyto.2022.155951","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T17:43:28Z","timestamp":1656351808000},"page":"155951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Differential cytokine profiles produced by anti-epileptic drug re-exposure of peripheral blood mononuclear cells derived from severe anti-epileptic drug patients and non-allergic controls"],"prefix":"10.1016","volume":"157","author":[{"given":"Yuttana","family":"Srinoulprasert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongsathorn","family":"Kumkamthornkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Papapit","family":"Tuchinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattawut","family":"Wongwiangjunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sith","family":"Sathornsumetee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kowit","family":"Jongjaroenprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanokvalai","family":"Kulthanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cyto.2022.155951_b0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/clpt.2011.79","article-title":"Phenotype standardization for immune-mediated drug-induced skin injury","volume":"89","author":"Pirmohamed","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.cyto.2022.155951_b0010","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.cyto.2022.155951_b0015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2230.2006.02185.x","article-title":"Epidemiological study of severe cutaneous adverse drug reactions in a city district of China","volume":"31","author":"Li","year":"2006","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.cyto.2022.155951_b0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.seizure.2019.07.015","article-title":"Rashes and other hypersensitivity reactions associated with antiepileptic drugs: A review of current literature","volume":"71","author":"Mani","year":"2019","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.cyto.2022.155951_b0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pharep.2014.11.009","article-title":"Antiepileptic drugs and adverse skin reactions: An update","volume":"67","author":"Blaszczyk","year":"2015","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.cyto.2022.155951_b0030","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/ern.10.71","article-title":"Adverse effects of antiepileptic drugs: a brief overview of important issues","volume":"10","author":"Cramer","year":"2010","journal-title":"Expert. Rev. Neurother."},{"issue":"3","key":"10.1016\/j.cyto.2022.155951_b0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D32197W4T4","article-title":"Phenytoin in cutaneous medicine: its uses, mechanisms and side effects","volume":"9","author":"Scheinfeld","year":"2003","journal-title":"Dermatol. Online. J."},{"issue":"6","key":"10.1016\/j.cyto.2022.155951_b0040","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.anai.2016.09.443","article-title":"Antiepilepsy drugs and the immune system","volume":"117","author":"Godhwani","year":"2016","journal-title":"Ann. Allergy. Asthma. Immunol."},{"issue":"15","key":"10.1016\/j.cyto.2022.155951_b0045","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinbiochem.2013.06.012","article-title":"Adverse drug reactions induced by valproic acid","volume":"46","author":"Nanau","year":"2013","journal-title":"Clin. Biochem."},{"issue":"15","key":"10.1016\/j.cyto.2022.155951_b0050","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.clinbiochem.2013.07.003","article-title":"Valproic acid derivatives signal for apoptosis and repair in vitro","volume":"46","author":"Neuman","year":"2013","journal-title":"Clin. Biochem."},{"issue":"10","key":"10.1016\/j.cyto.2022.155951_b0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1034\/j.1600-0714.2000.291003.x","article-title":"Effect of phenytoin on the production of interleukin-6 and interleukin-8 in human gingival fibroblasts","volume":"29","author":"Modeer","year":"2000","journal-title":"J. Oral. Pathol. Med."},{"issue":"6","key":"10.1016\/j.cyto.2022.155951_b0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00004850-200511000-00002","article-title":"Effect of valproate on plasma levels of interleukin-6 in healthy male humans","volume":"20","author":"Shiah","year":"2005","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.cyto.2022.155951_b0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10238-001-8024-1","article-title":"Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1","volume":"1","author":"Verrotti","year":"2001","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.cyto.2022.155951_b0070","doi-asserted-by":"crossref","unstructured":"W.J. Pichler, J. Adam, B. Daubner, T. Gentinetta, M. Keller, D. Yerly, Drug hypersensitivity reactions: pathomechanism and clinical symptoms, Med. Clin. North Am. 94(4) (2010) 645-64, xv.","DOI":"10.1016\/j.mcna.2010.04.003"},{"issue":"4","key":"10.1016\/j.cyto.2022.155951_b0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2332\/allergolint.10-RAI-0261","article-title":"Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis","volume":"59","author":"Chung","year":"2010","journal-title":"Allergol. Int."},{"issue":"9","key":"10.1016\/j.cyto.2022.155951_b0080","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1398-9995.2009.01985.x","article-title":"Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity","volume":"64","author":"Lochmatter","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.cyto.2022.155951_b0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-642-00663-0_2","article-title":"Drug hypersensitivity reactions involving skin","volume":"196","author":"Hausmann","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"issue":"2","key":"10.1016\/j.cyto.2022.155951_b0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1398-9995.2007.01516.x","article-title":"CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity","volume":"63","author":"Beeler","year":"2008","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.cyto.2022.155951_b0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2332\/allergolint.O-06-457","article-title":"Allergen-specific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay","volume":"56","author":"Tsuge","year":"2007","journal-title":"Allergol. Int."},{"issue":"1","key":"10.1016\/j.cyto.2022.155951_b0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1067\/mjd.2002.120473","article-title":"Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis","volume":"47","author":"Correia","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.cyto.2022.155951_b0105","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","article-title":"Evaluation of the potential role of cytokines in toxic epidermal necrolysis","volume":"123","author":"Nassif","year":"2004","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.cyto.2022.155951_b0110","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12145","article-title":"In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test","volume":"43","author":"Porebski","year":"2013","journal-title":"Clin. Exp. Allergy"},{"issue":"2","key":"10.1016\/j.cyto.2022.155951_b0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2222.1997.tb00690.x","article-title":"The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity","volume":"27","author":"Nyfeler","year":"1997","journal-title":"Clin. Exp. Allergy"},{"issue":"3","key":"10.1016\/j.cyto.2022.155951_b0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000358491","article-title":"Enhancement of drug-specific lymphocyte proliferation using CD25(hi)-depleted CD3(+) effector cells","volume":"163","author":"Srinoulprasert","year":"2014","journal-title":"Int. Arch. Allergy. Immunol."},{"issue":"3","key":"10.1016\/j.cyto.2022.155951_b0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cea.13076","article-title":"Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment","volume":"48","author":"Cabanas","year":"2018","journal-title":"Clin. Exp. Allergy"},{"issue":"9","key":"10.1016\/j.cyto.2022.155951_b0130","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1365-2222.2001.01164.x","article-title":"T cell involvement in cutaneous drug eruptions","volume":"31","author":"Hari","year":"2001","journal-title":"Clin. Exp. Allergy"},{"issue":"12","key":"10.1016\/j.cyto.2022.155951_b0135","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.cyto.2022.155951_b0140","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000448284","article-title":"Evaluation of Lymphocyte Transformation Test Results in Patients with Delayed Hypersensitivity Reactions following the Use of Anticonvulsant Drugs","volume":"170","author":"Karami","year":"2016","journal-title":"Int. Arch. Allergy. Immunol."},{"key":"10.1016\/j.cyto.2022.155951_b0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.intimp.2018.08.010","article-title":"Evaluation of a lymphocyte transformation test and cytokine detection assay to identify phenytoin and carbamazepine provoked DRESS or SJS\/TEN in epilepsy patients","volume":"63","author":"Kumkamthornkul","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.cyto.2022.155951_b0150","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.49.2.542","article-title":"Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study","volume":"49","author":"Tennis","year":"1997","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.cyto.2022.155951_b0155","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40264-019-00825-2","article-title":"Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances","volume":"42","author":"Bellon","year":"2019","journal-title":"Drug. Saf"},{"key":"10.1016\/j.cyto.2022.155951_b0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1479-5876-9-113","article-title":"Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays","volume":"9","author":"Kim","year":"2011","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.cyto.2022.155951_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/434010","article-title":"Cytokine levels in the serum of healthy subjects","volume":"2013","author":"Kleiner","year":"2013","journal-title":"Mediators. Inflamm."},{"issue":"5","key":"10.1016\/j.cyto.2022.155951_b0170","first-page":"1049","article-title":"Spontaneous cytokine production and its effect on induced production","volume":"9","author":"Walker","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.cyto.2022.155951_b0175","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/518265","article-title":"Production of the growth factors GM-CSF, G-CSF, and VEGF by human peripheral blood cells induced with metal complexes of human serum gamma -globulin formed with copper or zinc ions","volume":"2014","author":"Cheknev","year":"2014","journal-title":"Mediators. Inflamm."},{"issue":"2","key":"10.1016\/j.cyto.2022.155951_b0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.181.2.537","article-title":"Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production","volume":"181","author":"D'Andrea","year":"1995","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cyto.2022.155951_b0185","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/cea.12694","article-title":"Human memory CD4+ T cell response to the major dog allergen Can f 5, prostatic kallikrein","volume":"46","author":"Kailaanmaki","year":"2016","journal-title":"Clin. Exp. Allergy"},{"issue":"2 Suppl","key":"10.1016\/j.cyto.2022.155951_b0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/03946320040170S216","article-title":"Altered cytokine production in mice exposed to lead acetate","volume":"17","author":"Iavicoli","year":"2004","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"3","key":"10.1016\/j.cyto.2022.155951_b0195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00005-017-0501-7","article-title":"Allergen-Specific T Cells in IgE-Mediated Food Allergy","volume":"66","author":"Saidova","year":"2018","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"3","key":"10.1016\/j.cyto.2022.155951_b0200","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/QCO.0b013e3283298e62","article-title":"Molecular mechanisms of maculopapular exanthema","volume":"22","author":"Fernandez","year":"2009","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.cyto.2022.155951_b0205","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.4049\/jimmunol.1501092","article-title":"Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid Arthritis","volume":"195","author":"Mansour","year":"2015","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2022.155951_b0210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2005.10.030","article-title":"Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions","volume":"117","author":"Beeler","year":"2006","journal-title":"J. Allergy. Clin. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2022.155951_b0215","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","article-title":"A review of DRESS-associated myocarditis","volume":"66","author":"Bourgeois","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.cyto.2022.155951_b0220","first-page":"3","article-title":"Cardiac involvement in DRESS syndrome","volume":"35","author":"Thongsri","year":"2017","journal-title":"Asian. Pac. J. Allergy. Immunol."},{"key":"10.1016\/j.cyto.2022.155951_b0225","doi-asserted-by":"crossref","unstructured":"M.T. Chu, C.W. Wang, W.C. Chang, C.B. Chen, W.H. Chung, S.I. Hung, Granulysin-Based Lymphocyte Activation Test for Evaluating Drug Causality in Antiepileptics-Induced Severe Cutaneous Adverse Reactions, J. Invest. Dermatol. 141(6) (2021) 1461-1472 e10.","DOI":"10.1016\/j.jid.2020.11.027"},{"issue":"12","key":"10.1016\/j.cyto.2022.155951_b0230","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat. Med."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622001600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466622001600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:45:32Z","timestamp":1760910332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466622001600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"alternative-id":["S1043466622001600"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155951","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential cytokine profiles produced by anti-epileptic drug re-exposure of peripheral blood mononuclear cells derived from severe anti-epileptic drug patients and non-allergic controls","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2022.155951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155951"}}